Bjerknes Silje, Skogseid Inger Marie, Hauge Tuva Jin, Dietrichs Espen, Toft Mathias
Department of Neurology, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
NPJ Parkinsons Dis. 2020 Oct 14;6:29. doi: 10.1038/s41531-020-00131-0. eCollection 2020.
Parkinson's disease (PD) is a complex multisystem disorder with motor and non-motor symptoms (NMS). NMS may have an even greater impact on quality of life than motor symptoms. Subthalamic nucleus deep brain stimulation (STN-DBS) has been shown to improve motor fluctuations and quality of life, whereas the effects on different NMS have been less examined. Sleep disturbances and autonomic dysfunction are among the most prevalent NMS. We here report the efficacy of STN-DBS on sleep disturbances and autonomic dysfunction. In the parent trial, 60 patients were included in a single-center randomized prospective study, with MDS-UPDRS III and PDQ-39 as primary endpoints at 12 months of STN-DBS. Preplanned assessments at baseline and postoperatively at 3 and 12 months also included Parkinson's Disease Sleep Scale (PDSS); Scopa-Aut; and MDS-UPDRS I, II, and IV. We found that STN-DBS had a significant and lasting positive effect on overall sleep quality, nocturnal motor symptoms and restlessness, and daytime dozing. Several aspects of autonomic dysfunction were also improved at 3 months postoperatively, although at 12 months only thermoregulation (sudomotor symptoms) remained significantly improved. We could not identify preoperative factors that predicted improvement in PDSS or Scopa-Aut. There was a close relationship between improved autonomic symptoms and improved quality of life after 1 year. NMS and especially sleep and autonomic dysfunction deserve more focus to improve patient outcomes further.
帕金森病(PD)是一种复杂的多系统疾病,伴有运动和非运动症状(NMS)。NMS对生活质量的影响可能比运动症状更大。丘脑底核深部脑刺激(STN-DBS)已被证明可改善运动波动和生活质量,而其对不同NMS的影响则较少受到研究。睡眠障碍和自主神经功能障碍是最常见的NMS之一。我们在此报告STN-DBS对睡眠障碍和自主神经功能障碍的疗效。在母试验中,60名患者纳入了一项单中心随机前瞻性研究,以STN-DBS治疗12个月时的MDS-UPDRS III和PDQ-39作为主要终点。在基线以及术后3个月和12个月的预先计划评估还包括帕金森病睡眠量表(PDSS);Scopa-Aut;以及MDS-UPDRS I、II和IV。我们发现,STN-DBS对整体睡眠质量、夜间运动症状和不安以及日间打瞌睡有显著且持久的积极影响。自主神经功能障碍的几个方面在术后3个月也有所改善,尽管在12个月时只有体温调节(汗腺运动症状)仍有显著改善。我们无法确定预测PDSS或Scopa-Aut改善的术前因素。1年后自主神经症状改善与生活质量改善之间存在密切关系。NMS,尤其是睡眠和自主神经功能障碍,值得更多关注以进一步改善患者预后。